PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin PathwayBrigitte Grouix, Lyne Gagnon|Journal of Pharmacology and Experimental Therapeutics|2018Cited by 28